Canada's mandatory cannabis warning labels tripled health risk recall after legalization

Recall of cannabis health warnings tripled in Canada after legalization introduced mandatory large rotating labels, while recall remained flat in U.S. states with less comprehensive warning requirements.

Goodman, Samantha et al.·Substance use & misuse·2022·Moderate EvidenceCross-Sectional
RTHC-03882Cross SectionalModerate Evidence2022RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Cross-Sectional
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Free recall of at least one warning message increased from 5% (pre-legalization) to 15% in Canada post-legalization, significantly outpacing U.S. legal and illegal states. Awareness of specific warning messages was higher where those specific warnings were mandated on packages. More frequent consumers had higher recall.

Key Numbers

Canada: recall increased from 5% to 15% (3x increase). Compared to U.S. legal states: AOR 2.23. Recall higher among more frequent consumers.

How They Did This

Repeat cross-sectional surveys from the International Cannabis Policy Study (2018-2020) with 38,448 past-12-month cannabis consumers in Canada and the U.S. Free recall of warnings assessed 2018-2020; prompted recognition in 2020 only.

Why This Research Matters

Warning labels are a low-cost public health intervention. This study provides evidence they work for cannabis, particularly when mandated with large rotating messages as Canada requires.

The Bigger Picture

These findings parallel what has been established for tobacco: mandatory, prominent health warnings on packages measurably increase consumer awareness of health risks.

What This Study Doesn't Tell Us

Still relatively low absolute recall rates even in Canada (15%). Non-probability online samples. Cannot determine whether increased awareness changes behavior.

Questions This Raises

  • ?Does increased warning recall actually reduce cannabis use or risky consumption patterns?
  • ?Would larger or more graphic warnings further increase awareness?

Trust & Context

Key Stat:
Warning recall tripled in Canada post-legalization (5% to 15%)
Evidence Grade:
Multi-year repeat cross-sectional design across jurisdictions, though non-probability sampling and low absolute recall rates limit conclusions.
Study Age:
Published in 2022 with data from 2018-2020.
Original Title:
Do Mandatory Health Warning Labels on Consumer Products Increase Recall of the Health Risks of Cannabis?
Published In:
Substance use & misuse, 57(4), 569-580 (2022)
Database ID:
RTHC-03882

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

A snapshot of a population at one point in time.

What do these levels mean? →

Frequently Asked Questions

Do cannabis warning labels work?

Yes. Canada's mandated large rotating health warnings tripled recall of health risk messages from 5% to 15% after legalization, while recall stayed flat in U.S. states with less comprehensive requirements.

Which warnings were recalled most?

Recall was specific to what was mandated: awareness of particular warning messages was higher in jurisdictions where those specific warnings were required on packages.

Read More on RethinkTHC

Cite This Study

RTHC-03882·https://rethinkthc.com/research/RTHC-03882

APA

Goodman, Samantha; Leos-Toro, Cesar; Hammond, David. (2022). Do Mandatory Health Warning Labels on Consumer Products Increase Recall of the Health Risks of Cannabis?. Substance use & misuse, 57(4), 569-580. https://doi.org/10.1080/10826084.2021.2023186

MLA

Goodman, Samantha, et al. "Do Mandatory Health Warning Labels on Consumer Products Increase Recall of the Health Risks of Cannabis?." Substance use & misuse, 2022. https://doi.org/10.1080/10826084.2021.2023186

RethinkTHC

RethinkTHC Research Database. "Do Mandatory Health Warning Labels on Consumer Products Incr..." RTHC-03882. Retrieved from https://rethinkthc.com/research/goodman-2022-do-mandatory-health-warning

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.